TCL Archive Lagging Government Salaries Spur NCI Turnover Among Senior Staff, Threaten Cancer Program September 5, 1975
TCL Archive FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment. July 27, 2001
TCL Archive NCI advisors approved a proposal to set aside $75 million over the next five years to fund centers to study nutrition, energy balance, and physical activity. Also Board approves concepts for Cancer Disparities Networks, research in palliative care, and career awards for quantitative scientists. December 5, 2003
